News
MSD has unveiled new Phase 3 data on its blockbuster anti-PD-1 cancer therapy Keytruda (pembrolizumab) as part of a combination, this time with...
Check out this week's top 10 stories at Pharmafile.com now!
The US Food and Drug Administration (FDA) is offering a proposal to the International Council on Harmonisation (ICH) aimed at harmonising the...
Eli Lilly and patients with breast cancer patients in the UK have been dealt a blow as NICE confirmed that it has decided not to recommend the...
The international non-governmental organisation (NGO) Médecins Sans Frontières (MSF) has warned that antibiotic resistant infections are a “...
British MPs questioned the first robot to ever attend a UK parliamentary meeting this month, after a robot called Pepper offered insight into the...
GlaxoSmithKline’s workforce on President’s Island in Memphis, US, is set to see the loss of 99 employees, as revealed in a WARN notice filed with...
Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology to investigate...
The British government has extended the expiry date on epinephrine pens amid a shortage in the UK.
US pharma giant Pfizer is offering early retirement to American workers ahead of layoffs scheduled for next year.
